ERBB2 and breast carcinoma: To evaluate FOXP3 expression in IBC cells, we examined SUM149, a triple negative, basal type and SUM190, an ErbB2 overexpressing cell line, both of which are well established models isolated from IBC patient tumors, rSUM149 isogenic-derivative of SUM149 and compared them to non-IBC breast cancer cells (MCF-7, BT474, SKBR3), human mammary epithelial cells (HME1), Jurkat-E6, freshly isolated normal PBMCs, human monocytes and CD4+ T cells [31], [33].